Treatment of Psychosis in Parkinson’s DiseaseSafety Considerations

被引:0
|
作者
Hubert H. Fernandez
Martha E. Trieschmann
Joseph H. Friedman
机构
[1] Brown University School of Medicine,Department of Clinical Neurosciences
来源
Drug Safety | 2003年 / 26卷
关键词
Clozapine; Risperidone; Olanzapine; Quetiapine; Ziprasidone;
D O I
暂无
中图分类号
学科分类号
摘要
Psychosis only rarely occurs in patients with untreated Parkinson’s disease. Much more commonly, psychosis is induced by drug therapy for Parkinson’s disease and is the strongest known risk factor for nursing home placement. Delusions are less frequent than hallucinations, but are more concerning as they are often paranoid in nature. Treatment begins with a search for correctable infectious, toxic, and metabolic aetiologies. If symptoms persist, anti-Parkinson’s disease medications are slowly reduced. However, withdrawal of these drugs usually worsens parkinsonism and is often not tolerated. Certain atypical antipsychotics can be used to treat psychosis without compromising motor function.
引用
收藏
页码:643 / 659
页数:16
相关论文
共 50 条
  • [41] Evidence for using pimavanserin for the treatment of Parkinson's disease psychosis
    Tampi, Rajesh R.
    Tampi, Deena J.
    Young, Juan J.
    Balachandran, Silpa
    Hoq, Rakin A.
    Manikkara, Geetha
    WORLD JOURNAL OF PSYCHIATRY, 2019, 9 (03): : 47 - 54
  • [42] Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease
    Wolters, EC
    Jansen, ENH
    TuynmanQua, HG
    Bergmans, PLM
    NEUROLOGY, 1996, 47 (04) : 1085 - 1087
  • [43] Subthalamic DBS for the treatment of psychosis in advanced Parkinson's disease
    Fujimoto, K.
    Kawakami, T.
    Nakano, I.
    Koizumi, Y.
    Kato, S.
    MOVEMENT DISORDERS, 2006, 21 : S451 - S452
  • [44] Clinical Experience with Pimavanserin for Treatment of Parkinson's Disease Psychosis
    Sellers, Jessie
    Darby, Richard
    Claassen, Daniel
    NEUROLOGY, 2018, 90
  • [45] Olanzapine for the treatment of psychosis in patients with Parkinson's disease and dementia
    Marsh, L
    Lyketsos, C
    Reich, SG
    PSYCHOSOMATICS, 2001, 42 (06) : 477 - 481
  • [46] Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease
    Friedman, J
    NEUROLOGY, 1998, 50 (04) : 1195 - 1196
  • [47] Parenteral treatment of acute psychosis in Parkinson's disease with ziprasidone
    Oechsner, M
    Korchounov, A
    MOVEMENT DISORDERS, 2004, 19 : S213 - S213
  • [48] Dopaminomimetic psychosis in Parkinson's disease patients - Diagnosis and treatment
    Wolters, EC
    NEUROLOGY, 1999, 52 (07) : S10 - S13
  • [49] Pimavanserin Treatment for Parkinson's Disease Psychosis in Clinical Practice
    Dashtipour, Khashayar
    Gupta, Fiona
    Hauser, Robert A.
    Karunapuzha, Cherian A.
    Morgan, John C.
    PARKINSONS DISEASE, 2021, 2021
  • [50] Clozapine versus risperidone in the treatment of psychosis in Parkinson's disease
    Cudkowicz, ME
    Ellis, T
    Eggleston, P
    Growdon, JH
    NEUROLOGY, 1996, 46 (02) : 5126 - 5126